login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
MERCK & CO. INC. (MRK) Stock News
USA
-
New York Stock Exchange
- NYSE:MRK -
US58933Y1055
-
Common Stock
97.13
USD
+0.24 (+0.25%)
Last: 12/10/2025, 9:50:06 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MRK Latest News, Press Relases and Analysis
All
Press Releases
22 hours ago - By: Chartmill
- Mentions:
NEM
TAP
CPB
APP
...
Explore the top gainers and losers within the S&P500 index in today's session.
12 days ago - By: Chartmill
Merck & Co. Inc. (NYSE:MRK): A Dividend Stock with Strong Profitability and Financial Health
20 hours ago - By: Zacks Investment Research
- Mentions:
BMY
JNJ
PFE
LLY
...
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal
a day ago - By: The Motley Fool
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump
a day ago - By: The Motley Fool
- Mentions:
LLY
JNJ
ABBV
1 Major Factor Behind the Healthcare Sector's Recent Surge
a day ago - By: Zacks Investment Research
- Mentions:
MRNA
CDTX
SMMT
MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?
a day ago - By: Zydus Lifesciences
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
2 days ago - By: Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
2 days ago - By: Zacks Investment Research
- Mentions:
NRG
NFLX
WBD
VSCO
Company News for Dec 8, 2025
2 days ago - By: Zacks Investment Research
- Mentions:
FCX
WMT
AMAT
CVNA
Watch 5 Bigwigs in December After Double-Digit Returns Past Month
2 days ago - By: Bloomberg
- Mentions:
GEHC
Companies Are Rushing to Bond Markets for Cut-Price M&A Funding
6 days ago - By: Merck & Co., Inc.
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)
6 days ago - By: Zacks Investment Research
- Mentions:
JNJ
UTHR
Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?
8 days ago - By: Zacks Investment Research
- Mentions:
PFE
AZN
BMY
Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure
8 days ago - By: Zacks Investment Research
Why Merck (MRK) is a Top Growth Stock for the Long-Term
8 days ago - By: BioMedWire
- Mentions:
SNGX
PFE
BMY
INSM
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
9 days ago - By: Zacks Investment Research
Here's Why Merck (MRK) is a Strong Momentum Stock
9 days ago - By: Bloomberg
- Mentions:
CDTX
Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal
9 days ago - By: Merck Sharp & Dohme
Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025
12 days ago - By: Zacks Investment Research
- Mentions:
AZN
JNJ
PFE
JNJ's Oncology Momentum Builds as It Chases $50B Goal by 2030
13 days ago - By: Zacks Investment Research
- Mentions:
BMY
Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?
13 days ago - By: Zacks Investment Research
- Mentions:
AZN
CDTX
SMMT
AstraZeneca or Merck: Which Oncology Giant Has the Edge?
13 days ago - By: Zacks Investment Research
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Please enable JavaScript to continue using this application.